Sestina Bio leverages advanced biomanufacturing technologies to create affordable and sustainable products through its innovative GenoScaler™ platform. This platform revolutionizes the traditional strain engineering process by enabling the identification and recombination of genetic edits that yield strains with the highest commercial potential. By utilizing machine learning models, GenoScaler™ efficiently navigates large genetic sequence spaces, significantly accelerating the strain improvement cycle to just 2-4 weeks. This approach is not only faster—being four times quicker than conventional methods—but also drastically more cost-effective, reducing expenses to approximately $0.10 per variant and requiring fewer resources per project.

Additionally, Sestina Bio employs its Lean Bioengineering™ methodology, which integrates Directed Evolution, CRISPR+, and machine learning to enhance the biomanufacturing process. This combination results in increased success rates, shorter timelines, and lower costs, making the overall process more scalable and safe. By focusing on the discovery and combinatorial testing of beneficial genetic changes, Sestina Bio aims to transform the landscape of biomanufacturing, ultimately contributing to the development of a sustainable bioeconomy.

United States

Inscripta® is a life science technology company committed to creating a cleaner, healthier, and more sustainable world through biomanufacturing. A global leader in genome engineering, our innovations are designed to unlock the full potential of the bioeconomy. We are committed to the continued development of critical technologies that enable scientists to bolster and expand domestic biomanufacturing, and spur new, safe, and secure biotech innovations. Inscripta supports customers around the world from facilities in Pleasanton and Burlingame, California.
To learn more, visit Inscripta.com and follow @InscriptaInc.

Sestina Bio

Company Details